Nova Eye Medical Limited (ASX: EYE) Bell Potter Healthcare Conference 2026 Tuesday 17 November 2026 | Q1 FY27 | Tom Spurling, Managing Director Disclaimer This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good...
Bell Potter Healthcare Conference Presentation
Filed with ASX · · 19 pages · English
Summary by 6ix AI
Nova Eye Medical Ltd presented at the Bell Potter Healthcare Conference, discussing its growth and financial performance for the first quarter of the fiscal year. The company reported a significant increase in sales compared to the previous corresponding period, highlighting strong revenue growth in the interventional glaucoma market. Cash flow from operations turned positive, indicating improved financial health and operational efficiency. The presentation confirmed guidance for the fiscal year, projecting continued growth in sales and positive EBITDA.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Story so far
Earlier from Nova Eye Medical
- EYE to Present @ Bell Potter Healthcare Conference 2026
- First Sale iTrack Advance in South Korea
- Appendix 3Y Thomas Duthy
- Appendix 3X Dr T Duthy
- Appendix 3Z Coupe
Later from Nova Eye Medical
- Notification of cessation of securities - EYE
- Notification regarding unquoted securities - EYE
- Application for quotation of securities - EYE
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical